Cargando…

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy

Interleukin-2 (IL-2) therapy has been demonstrated to induce responses in 10-20% of advanced melanoma and renal cell carcinoma patients, which translates into durable remissions in up to half of the responsers. Unfortunately the use of IL-2 has been associated with severe toxicity and death. It has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Samuel C, Markosian, Boris, Ajili, Naseem, Dolan, Brandon R, Kim, Andy J, Alexandrescu, Doru T, Dasanu, Constantin A, Minev, Boris, Koropatnick, James, Marincola, Francesco M, Riordan, Neil H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028098/ https://www.ncbi.nlm.nih.gov/pubmed/24884532 http://dx.doi.org/10.1186/1479-5876-12-127

Ejemplares similares

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
por: Ichim, Thomas E, et al.
Publicado: (2011)

Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy
por: Mikirova, Nina, et al.
Publicado: (2016)

Combination stem cell therapy for heart failure
por: Ichim, Thomas E, et al.
Publicado: (2010)

Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
por: Mikirova, Nina A, et al.
Publicado: (2009)

Lasers, stem cells, and COPD
por: Lin, Feng, et al.
Publicado: (2010)

Exogenous endothelial cells as accelerators of hematopoietic reconstitution
por: Mizer, J Christopher, et al.
Publicado: (2012)

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients
por: Mikirova, Nina, et al.
Publicado: (2013)

Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for creutzfeldt-jakob disease
por: McKnight, Alexia L, et al.
Publicado: (2010)

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
por: Nauman, Gina, et al.
Publicado: (2018)

Administration of Intravenous Ascorbic Acid—Practical Considerations for Clinicians
por: Walker, Scott E., et al.
Publicado: (2019)

Exosomes as a tumor immune escape mechanism: possible therapeutic implications
por: Ichim, Thomas E, et al.
Publicado: (2008)

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
por: Kang, Dae Woong, et al.
Publicado: (2012)

Role of Intravenous Ascorbic Acid in the Management of Anemia in Hemodialysis Patients
por: El Shinnawy, Howayda, et al.
Publicado: (2021)

Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
por: Wagner, Brett A., et al.
Publicado: (2023)

Anti-angiogenic effect of high doses of ascorbic acid
por: Mikirova, Nina A, et al.
Publicado: (2008)

A Case of Factitious Hyperglycemia in a Patient on Intravenous Ascorbic Acid
por: Sharma, Eliza, et al.
Publicado: (2018)

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
por: Bazzan, Anthony J., et al.
Publicado: (2018)

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours
por: Casciari, J J, et al.
Publicado: (2001)

Usefulness of dexmedetomidine as an intravenous adjuvant
por: Parthasarathy, S.
Publicado: (2020)

Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
por: Jalalzadeh, M., et al.
Publicado: (2012)

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
por: Fowler, Alpha A, et al.
Publicado: (2014)

Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
por: Sokary, Sara, et al.
Publicado: (2022)

Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy
por: Pagni, Roberta Liberato, et al.
Publicado: (2022)

Ascorbic Acid as an Adjuvant to Unbleached Cotton Promotes Antimicrobial Activity in Spunlace Nonwovens
por: Edwards, Judson Vincent, et al.
Publicado: (2022)

Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
por: Zaher, Amira, et al.
Publicado: (2022)

Overcoming tumor immune evasion with an unique arbovirus
por: Lyday, Bruce, et al.
Publicado: (2015)

TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant
por: Saenz, Rebecca, et al.
Publicado: (2014)

Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016)

Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo
por: Mikirova, Nina A, et al.
Publicado: (2010)

Emerging Adjuvants for Cancer Immunotherapy
por: Hu, Hong-Guo, et al.
Publicado: (2020)

Curcumin as an Adjuvant to Cancer Immunotherapy
por: Paul, Silpita, et al.
Publicado: (2021)

Membrane Permeabilities of Ascorbic Acid and Ascorbate
por: Hannesschlaeger, Christof, et al.
Publicado: (2018)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
por: Lim, Seula, et al.
Publicado: (2019)

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
por: Ma, Wenxue, et al.
Publicado: (2011)

Introducing the society for immunotherapy of cancer’s new journal: journal for immunoTherapy of cancer
por: Romero, Pedro J, et al.
Publicado: (2013)

Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
por: Minev, Boris, et al.
Publicado: (2014)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
por: Monti, Daniel A., et al.
Publicado: (2012)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
por: Wang, Huiqiang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lmpvp6t5kjqn4cr20e6mo0b2mi